Menopausal Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women aged 40–60 years who meet the diagnostic criteria for perimenopause/with a modified Kupperman Index (KI) score of >=6 points. 2. Women who have a need for decision-making regarding menopausal hormone therapy (MHT). 3. Women who have provided informed consent and are willing to cooperate to complete this study.
Exclusion criteria
Exclusion criteria: 1. Women who have no spontaneous menstruation due to premature ovarian failure, primary amenorrhea, secondary amenorrhea, etc. 2. Women who have undergone hysterectomy. 3. Women with contraindications to menopausal hormone therapy (MHT) (known or suspected pregnancy, unexplained vaginal bleeding, known or suspected breast cancer, etc.). 4. Women with intellectual and cognitive impairments, excluding organic mental disorders, and unable to communicate effectively through normal speech. 5. Women who have experienced major stressful events within the past three months, such as bereavement, unemployment, or divorce.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| experience of decision making; | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction with decision-making participation; | — |
Countries
China
Contacts
Second Affiliated Hospital of Shantou University Medical College